Escherichia coli sequence type 131 (ST131) is currently one of the leading causes of multidrug-resistant extraintestinal infections globally. Here, we analyzed the phenotypic and genotypic characteristics of 169 ST131 isolates from various sources (wildlife, wastewater, companion animals, community, and hospitals) to determine whether wildlife and the environment share similar strains with humans, supporting transmission of ST131 between different ecological niches. Susceptibility to 32 antimicrobials was tested by disc diffusion and broth microdilution. Antibiotic resistance genes, integrons, plasmid replicons, 52 virulence genes, and fimH-based subtypes were detected by PCR and DNA sequencing. Genomic relatedness was determined by pulsed-field gel electrophoresis (PFGE). The genetic context and plasmid versus chromosomal location of extended-spectrum beta-lactamase and AmpC beta-lactamase genes was determined by PCR and probe hybridization, respectively. The 169 ST131 study isolates segregated predominantly into blaCTX-M-15H30Rx (60%) and blaCTX-M-27H30R1 (25%) subclones. Within each subclone, isolates from different source groups were categorized into distinct PFGE clusters; genotypic characteristics were fairly well conserved within each major PFGE cluster. Irrespective of source, the blaCTX-M-15H30Rx isolates typically exhibited virotype A (89%), an F2:A1:B- replicon (84%), and a 1.7-kb class 1 integron (92%) and had diverse structures upstream of the blaCTX-M region. In contrast, the blaCTX-M-27H30R1 isolates typically exhibited virotype C (86%), an F1:A2:B20 replicon (76%), and a conserved IS26-ΔISEcp1-blaCTX-M-like structure. Despite considerable overall genetic diversity, our data demonstrate significant commonality between E. coli ST131 isolates from diverse environments, supporting transmission between different sources, including humans, environment, and wildlife.

Biomedical Center Faculty of Medicine Charles University Pilsen Czech Republic

CEITEC University of Veterinary and Pharmaceutical Sciences Brno Brno Czech Republic

Department of Biology and Wildlife Diseases Faculty of Veterinary Hygiene and Ecology University of Veterinary and Pharmaceutical Sciences Brno Brno Czech Republic

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Microbiology Faculty of Medicine and University Hospital Pilsen Charles University Pilsen Czech Republic

Research Centre for Toxic Compounds in the Environment Faculty of Science Masaryk University Brno Czech Republic

Veterans Affairs Medical Center and University of Minnesota Minneapolis Minnesota USA

Zobrazit více v PubMed

Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58:4997–5004. doi:10.1128/AAC.02824-14. PubMed DOI PMC

Mathers AJ, Peirano G, Pitout JD. 2015. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 28:565–591. doi:10.1128/CMR.00116-14. PubMed DOI PMC

Nicolas-Chanoine MH, Bertrand X, Madec JY. 2014. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543–574. doi:10.1128/CMR.00125-13. PubMed DOI PMC

Johnson TJ, Danzeisen JL, Youmans B, Case K, Llop K, Munoz-Aguayo J, Flores-Figueroa C, Aziz M, Stoesser N, Sokurenko E, Price LB, Johnson JR. 2016. Separate F-type plasmids have shaped the evolution of the H30 subclone of Escherichia coli sequence type 131. mSphere 1:e00121-16. doi:10.1128/mSphere.00288-16. PubMed DOI PMC

Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4:10. doi:10.1128/mBio.00377-13. PubMed DOI PMC

Johnson JR, Porter S, Thuras P, Castanheira M. 2017. The pandemic H30 subclone of sequence type 131 (ST131) as the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011-2012). Open Forum Infect Dis 4:ofx089. doi:10.1093/ofid/ofx089. PubMed DOI PMC

Ben Zakour NL, Alsheikh-Hussain AS, Ashcroft MM, Khanh Nhu NT, Roberts LW, Stanton-Cook M, Schembri MA, Beatson SA. 2016. Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131. mBio 7:e00347-. doi:10.1128/mBio.00958-16. PubMed DOI PMC

Olesen B, Frimodt-Moller J, Leihof RF, Struve C, Johnston B, Hansen DS, Scheutz F, Krogfelt KA, Kuskowski MA, Clabots C, Johnson JR. 2014. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012. Antimicrob Agents Chemother 58:6886–6895. doi:10.1128/AAC.03679-14. PubMed DOI PMC

Peirano G, van der Bij AK, Freeman JL, Poirel L, Nordmann P, Costello M, Tchesnokova VL, Pitout JD. 2014. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum beta-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agents Chemother 58:3762–3767. doi:10.1128/AAC.02428-14. PubMed DOI PMC

Dahbi G, Mora A, Mamani R, Lopez C, Alonso MP, Marzoa J, Blanco M, Herrera A, Viso S, Garcia-Garrote F, Tchesnokova V, Billig M, de la Cruz F, de Toro M, Gonzalez-Lopez JJ, Prats G, Chaves F, Martinez-Martinez L, Lopez-Cerezo L, Denamur E, Blanco J. 2014. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131. Int J Med Microbiol 304:1247–1257. doi:10.1016/j.ijmm.2014.10.002. PubMed DOI

Matsumura Y, Johnson JR, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S. 2015. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. J Antimicrob Chemother 70:1639–1649. doi:10.1093/jac/dkv017. PubMed DOI

Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. 2015. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis 15:168. doi:10.1186/s12879-015-0880-5. PubMed DOI PMC

Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernandez V, de la Cruz F, Martinez-Martinez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, Lopez-Cerero L, Pascual A, Rodriguez-Bano J. 2013. Four main virotypes among extended-spectrum-beta-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol 51:3358–3367. doi:10.1128/JCM.01555-13. PubMed DOI PMC

Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 18:598–607. doi:10.3201/eid1804.111627. PubMed DOI PMC

Stoesser N, Sheppard AE, Pankhurst L, De Maio N, Moore CE, Sebra R, Turner P, Anson LW, Kasarskis A, Batty EM, Kos V, Wilson DJ, Phetsouvanh R, Wyllie D, Sokurenko E, Manges AR, Johnson TJ, Price LB, Peto TE, Johnson JR, Didelot X, Walker AS, Crook DW. 2016. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 7:e02162-15. doi:10.1128/mBio.02162-15. PubMed DOI PMC

Platell JL, Johnson JR, Cobbold RN, Trott DJ. 2011. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 153:99–108. doi:10.1016/j.vetmic.2011.05.007. PubMed DOI

Kim SY, Park YJ, Johnson JR, Yu JK, Kim YK, Kim YS. 2016. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea. Diagn Microbiol Infect Dis 84:97–101. doi:10.1016/j.diagmicrobio.2015.10.016. PubMed DOI

Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, Pomputius W, Ender PT, Cooperstock M, Slater BS, Banerjee R, Miller S, Kisiela D, Sokurenko EV, Aziz M, Price LB. 2016. Household clustering of Escherichia coli sequence type 131 clinical and fecal isolates according to whole-genome sequence analysis. Open Forum Infect Dis 3:ofw129. doi:10.1093/ofid/ofw129. PubMed DOI PMC

Matsumura Y, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S. 2013. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-beta-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. Antimicrob Agents Chemother 57:4736–4742. doi:10.1128/AAC.00641-13. PubMed DOI PMC

Doumith M, Dhanji H, Ellington MJ, Hawkey P, Woodford N. 2012. Characterization of plasmids encoding extended-spectrum beta-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J Antimicrob Chemother 67:878–885. doi:10.1093/jac/dkr553. PubMed DOI

Dhanji H, Patel R, Wall R, Doumith M, Patel B, Hope R, Livermore DM, Woodford N. 2011. Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom. J Antimicrob Chemother 66:1005–1012. doi:10.1093/jac/dkr041. PubMed DOI

Lupo A, Coyne S, Berendonk TU. 2012. Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies. Front Microbiol 3:18. doi:10.3389/fmicb.2012.00018. PubMed DOI PMC

Brechet C, Plantin J, Sauget M, Thouverez M, Talon D, Cholley P, Guyeux C, Hocquet D, Bertrand X. 2014. Wastewater treatment plants release large amounts of extended-spectrum beta-lactamase-producing Escherichia coli into the environment. Clin Infect Dis 58:1658–1665. doi:10.1093/cid/ciu190. PubMed DOI

Muller A, Stephan R, Nuesch-Inderbinen M. 2016. Distribution of virulence factors in ESBL-producing Escherichia coli isolated from the environment, livestock, food and humans. Sci Total Environ 541:667–672. doi:10.1016/j.scitotenv.2015.09.135. PubMed DOI

Jamborova I, Dolejska M, Vojtech J, Guenther S, Uricariu R, Drozdowska J, Papousek I, Pasekova K, Meissner W, Hordowski J, Cizek A, Literak I. 2015. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe. Appl Environ Microbiol 81:648–657. doi:10.1128/AEM.02459-14. PubMed DOI PMC

Jamborova I, Dolejska M, Zurek L, Townsend AK, Clark AB, Ellis JC, Papousek I, Cizek A, Literak I. 2017. Plasmid-mediated resistance to cephalosporins and quinolones in Escherichia coli from American crows in the U S A. Environ Microbiol 19:2025–2036. doi:10.1111/1462-2920.13722. PubMed DOI

von Salviati C, Laube H, Guerra B, Roesler U, Friese A. 2015. Emission of ESBL/AmpC-producing Escherichia coli from pig fattening farms to surrounding areas. Vet Microbiol 175:77–84. doi:10.1016/j.vetmic.2014.10.010. PubMed DOI

Laube H, Friese A, von Salviati C, Guerra B, Rosler U. 2014. Transmission of ESBL/AmpC-producing Escherichia coli from broiler chicken farms to surrounding areas. Vet Microbiol 172:519–527. doi:10.1016/j.vetmic.2014.06.008. PubMed DOI

Hartmann A, Locatelli A, Amoureux L, Depret G, Jolivet C, Gueneau E, Neuwirth C. 2012. Occurrence of CTX-M-producing Escherichia coli in soils, cattle, and farm environment in France (Burgundy region). Front Microbiol 3:83. doi:10.3389/fmicb.2012.00083. PubMed DOI PMC

Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I. 2011. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J Antimicrob Chemother 66:2784–2790. doi:10.1093/jac/dkr363. PubMed DOI

Dolejska M, Brhelova E, Dobiasova H, Krivdova J, Jurankova J, Sevcikova A, Dubska L, Literak I, Cizek A, Vavrina M, Kutnikova L, Sterba J. 2012. Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards. Int J Antimicrob Agents 40:510–515. doi:10.1016/j.ijantimicag.2012.07.016. PubMed DOI

Tausova D, Dolejska M, Cizek A, Hanusova L, Hrusakova J, Svoboda O, Camlik G, Literak I. 2012. Escherichia coli with extended-spectrum beta-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe. J Antimicrob Chemother 67:1103–1107. doi:10.1093/jac/dks017. PubMed DOI

Micenkova L, Siskova P, Bosak J, Jamborova I, Cernohorska L, Smajs D. 2014. Characterization of human uropathogenic ESBL-producing Escherichia coli in the Czech Republic: spread of CTX-M-27-producing strains in a University Hospital. Microb Drug Resist 20:610–617. doi:10.1089/mdr.2014.0013. PubMed DOI

Albrechtova K, Dolejska M, Cizek A, Tausova D, Klimes J, Bebora L, Literak I. 2012. Dogs of nomadic pastoralists in northern Kenya are reservoirs of plasmid-mediated cephalosporin- and quinolone-resistant Escherichia coli, including pandemic clone B2-O25-ST131. Antimicrob Agents Chemother 56:4013–4017. doi:10.1128/AAC.05859-11. PubMed DOI PMC

Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:2733–2739. doi:10.1128/AAC.00297-09. PubMed DOI PMC

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR. 2013. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 57:1256–1265. doi:10.1093/cid/cit503. PubMed DOI PMC

Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E. 2014. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 52:1358–1365. doi:10.1128/JCM.03502-13. PubMed DOI PMC

Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228. doi:10.1016/j.mimet.2005.03.018. PubMed DOI

Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 65:2518–2529. doi:10.1093/jac/dkq347. PubMed DOI

Johnson JR, Porter S, Johnston B, Kuskowski MA, Spurbeck RR, Mobley HL, Williamson DA. 2015. Host characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates from patients with urosepsis. Open Forum Infect Dis 2:ofv083. doi:10.1093/ofid/ofv133.98. PubMed DOI PMC

Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA, Smith KE. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 47:2161–2168. doi:10.1128/AAC.47.7.2161-2168.2003. PubMed DOI PMC

CLSI. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Document M100-S24. CLSI, Wayne, PA.

European Committee on Antimicrobial Susceptibility Testing. g. 2015. Breakpoint tables for interpretation of MICs and zone diameters, version 5.0 European Committee on Antimicrobial Susceptibility Testing, Vaxjo, Sweden: http://www.eucast.org/clinical_breakpoints/.

Studentova V, Dobiasova H, Hedlova D, Dolejska M, Papagiannitsis CC, Hrabak J. 2015. Complete nucleotide sequences of two NDM-1-encoding plasmids from the same sequence type 11 Klebsiella pneumoniae strain. Antimicrob Agents Chemother 59:1325–1328. doi:10.1128/AAC.04095-14. PubMed DOI PMC

Peakall R, Smouse PE. 2012. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics 28:2537–2539. PubMed PMC

Antibiotic-resistant Escherichia coli from treated municipal wastewaters and Black-headed Gull nestlings on the recipient river

Genomic comparisons of Escherichia coli ST131 from Australia

Clinical isolates of Escherichia coli are resistant both to antibiotics and organotin compounds